Federated Hermes Inc. Takes $290,000 Position in PetMed Express, Inc. (NASDAQ:PETS)

Federated Hermes Inc. acquired a new position in PetMed Express, Inc. (NASDAQ:PETS) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 38,389 shares of the company’s stock, valued at approximately $290,000.

Several other large investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC acquired a new stake in shares of PetMed Express in the 4th quarter valued at $36,000. L2 Asset Management LLC acquired a new stake in PetMed Express in the third quarter worth about $108,000. Quadrature Capital Ltd raised its holdings in PetMed Express by 127.2% during the 3rd quarter. Quadrature Capital Ltd now owns 29,597 shares of the company’s stock worth $303,000 after purchasing an additional 16,573 shares during the last quarter. Numerai GP LLC acquired a new position in PetMed Express during the 3rd quarter valued at about $216,000. Finally, Profit Investment Management LLC lifted its position in PetMed Express by 19.3% during the 4th quarter. Profit Investment Management LLC now owns 182,333 shares of the company’s stock valued at $1,378,000 after purchasing an additional 29,438 shares during the period. Institutional investors and hedge funds own 73.33% of the company’s stock.

PetMed Express Price Performance

Shares of NASDAQ:PETS opened at $4.05 on Friday. The company has a 50 day moving average of $4.58 and a 200-day moving average of $6.28. PetMed Express, Inc. has a one year low of $3.92 and a one year high of $16.18. The stock has a market cap of $85.66 million, a price-to-earnings ratio of -10.38 and a beta of 0.73.

PetMed Express (NASDAQ:PETS) last issued its earnings results on Monday, April 15th. The company reported ($0.10) EPS for the quarter. The business had revenue of $65.32 million for the quarter. PetMed Express had a negative net margin of 2.92% and a negative return on equity of 1.25%. Equities research analysts anticipate that PetMed Express, Inc. will post 0.01 earnings per share for the current year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.